Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALS

Article Related Articles (1) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 5/25/2022

1. SPY
2. SNAP
3. ZM
4. HIVE
5. CRM

6. TWTR
7. FB
8. TLT
9. ALB

Top News Most Read Special Reports

S&P 500, Nasdaq slide as weak economic data, dire outlooks stoke recession fears
'Snap Drops a Bomb': Snap (SNAP) Stock Crashes Nearly 30% on Forecast Cut, Musk-Twitter Saga to Get a 'Whole Lot More Interesting' Says Analyst
Bill Ackman Says Fed Must Aggressively Raise Rates Now to Combat Inflation or Economy Will Collapse
Intuit Shares Gain 3% on Q3 Earnings Beat and Raise
After-Hours Stock Movers 05/24: Wendy's Gains on Possible Peltz Deal, Nordstrom Up Following Earnings (more...)

Go back to Ionis' partner Biogen provides update on tofersen Phase 3 VALOR study in SOD1-ALS

(NASDAQ: IONS)						Delayed: 37.11 -2.36 (5.98%)
Previous Close	$39.47		52 Week High	$62.68
Open	$39.02		52 Week Low	$19.59
Day High	$39.52		P/E	N/A
Day Low	$36.99		EPS	$0.00
Volume	1,089,540